New York, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of $2.9 million registered direct offering (the “Offering”) for its client WORK Medical Technology Group LTD (NASDAQ: WOK) (the “Company”), a supplier of medical devices in China. Under the terms of the securities purchase agreement, the Company has agreed to sell to several investors ...

Hangzhou, China, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into an agreement with several investors for the purchase and sale of 38,999,334 of the Company’s Class A ordinary share, par value $0.0005 per share (the “Shares”) (or pre-funded warrants in ...

该医疗器械制造商计划运用 RWA 技术，改造并利用现有产品架构和新兴的人工智能业务 Key takeaways: 中国香港从今年8月1日开启拥抱虚拟资产的新时代——正式推出名为稳定币的虚拟货币监管和许可框架。 此后，不断有中国企业在该市场开始探索多个行业领域的虚拟资产及其底层区块链技术。 医疗器械制造商 沃氪医疗科技集团有限公司 （WOK.US）也是其中之一。公司宣布携手香港Web3.0标准化 协会，启动探索RWA（现实世界资产）通证化及相关区块链技术的重大新计划。香港Web3.0标准化协会的 宗旨是通过标准化研究推动全球Web3.0产业高质量发展。 此次合作正值沃氪医疗登陆纳斯达克一年后，是其持续进化的"Healthcare + Payment + Technology = RWA + Web3 + AI"战略组成部分。公司还计划与金融领域若干拥有合格资质的机构展开战略协作，为资产通证化 蓝图搭建关键合规通道。 数字货币做市商Keyrock与通证化平台Centrifuge五月联合报告显示，通证化RWA（具有价值的数字化现实 世界资产）规模预计将在年底突破500亿美元。报告同时指出，美国国债将主导该市场，仅相 ...

股价显著下跌公司表现 - WORK Medical Technology Group Ltd股价下跌约88%至0.1美元 公司专注于一次性医疗器械并通过与瑞金医院无锡分院合作开发AI驱动医疗产品以增强临床生态系统[1][7] - BT Brands Inc股价下跌34%至0.16美元 公司运营Burger Time和Dairy Queen等快餐连锁 业务受消费者周期性趋势影响且依赖消费者支出习惯[2][7] - Fitness Champs Holdings Limited股价下跌33%至0.71美元 公司近期以每股4美元价格完成375万股首次公开募股 在新加坡从事体育教育和商品销售业务[3][7] - SAIHEAT Limited股价下跌32%至0.18美元 公司专注于液态冷却数据中心和高性能服务器领域 致力于可持续数据中心解决方案的创新[4][7] - Zhengye Biotechnology Holding Limited股价下跌28%至5.01美元 公司专精于兽用疫苗领域 联合首席执行官宋松林称2024财年为转型年 通过战略决策实现客户群多元化[5] 行业动态与战略重点 - 医疗科技行业通过AI驱动产品开发和战略合作增强临床生态系统[1][7] - 快餐行业受消费者周期性趋势影响 业绩与消费者支出习惯密切相关[2][7] - 体育教育行业通过公开募股拓展业务 持续贡献于体育教育和商品销售[3] - 数据中心技术行业聚焦液态冷却解决方案和高性能服务器 强调高效计算生态系统的重要性[4][7] - 生物科技行业通过客户群多元化和战略决策确保长期增长 专注于兽医疫苗领域[5]

The medical products maker hopes to leverage RWA technology to transform and leverage its current product infrastructure and budding AI businessKey Takeaways:WORK Medical has formed a new alliance with the Hong Kong Web3.0 Standardization Association and was appointed as the organization's "council vice chairman."The company has also entered into a collaboration with Ruijin Hospital's Wuxi Branch to accelerate the development of a next-generation, AI-driven smart clinical ecosystemHong Kong kicked off a new ...

Hangzhou, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into a strategic cooperation agreement (the “Agreement”) with Hong Kong Web3.0 Standardization Association Limited (the “Association”), an organization dedicated to standardization research in ...

Hangzhou, China, Sept. 22, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. (“Work Hangzhou”) and its subsidiaries in China, today announced the signing of a strategic cooperation agreement (the “Agreement”) between Work Hangzhou and the Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine (“Xin Rui Hospita ...

股价表现 - 8月20日开盘上涨4.8%至0.83美元/股 成交额4824美元 总市值4692.37万美元[1] 财务数据 - 截至2024年09月30日收入总额1150.64万美元 同比下降15.18%[1] - 归母净利润-349.23万美元 同比大幅下降3217.31%[1] 公司背景 - 注册于开曼群岛 通过境内实体杭州山友医疗器械有限公司运营[1] - 子公司成立于2002年4月 专业生产麻醉/呼吸/急救/ICU/介入/口罩等医疗消耗品[1] - 引进国内外先进塑料注塑/挤塑成形/包装封口等专业设备[1]

股价表现 - 8月18日开盘上涨3.72%至0.8美元/股 成交额156美元 总市值4522.77万美元 [1] 财务数据 - 截至2024年09月30日收入总额1150.64万美元 同比下降15.18% [1] - 归母净利润-349.23万美元 同比大幅下降3217.31% [1] 公司背景 - 注册于开曼群岛 主要通过境内实体杭州山友医疗器械有限公司运营 [1] - 子公司成立于2002年4月 专业生产麻醉/呼吸/急救/ICU/介入/口罩等医疗消耗品 [1] - 拥有塑料注塑、挤塑成形、包装封口等专业生产设备 [1]

股价表现 - 8月14日开盘上涨2.5% 报0.8美元/股 成交129.0美元 总市值4522.77万美元 [1] 财务数据 - 截至2024年09月30日收入总额1150.64万美元 同比减少15.18% [1] - 归母净利润-349.23万美元 同比减少3217.31% [1] 公司背景 - 注册于开曼群岛 主要通过境内实体杭州山友医疗器械有限公司运营 [1] - 子公司成立于2002年4月 专业生产麻醉/呼吸/急救/ICU/介入/口罩等医疗消耗品 [1] - 引进国内外先进塑料注塑/挤塑成形/包装封口等专业设备 [1]